- Home
- MHF vs MYO Comparison
MHF vs MYO Comparison
Compare MHF & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHF
- MYO
- Stock Information
- Founded
- MHF 1988
- MYO 2004
- Country
- MHF United States
- MYO United States
- Employees
- MHF N/A
- MYO N/A
- Industry
- MHF Finance/Investors Services
- MYO Industrial Specialties
- Sector
- MHF Finance
- MYO Health Care
- Exchange
- MHF Nasdaq
- MYO Nasdaq
- Market Cap
- MHF 145.5M
- MYO 153.0M
- IPO Year
- MHF N/A
- MYO 2017
- Fundamental
- Price
- MHF $6.92
- MYO $1.09
- Analyst Decision
- MHF
- MYO Strong Buy
- Analyst Count
- MHF 0
- MYO 3
- Target Price
- MHF N/A
- MYO $8.17
- AVG Volume (30 Days)
- MHF 57.2K
- MYO 860.8K
- Earning Date
- MHF 01-01-0001
- MYO 08-11-2025
- Dividend Yield
- MHF 4.29%
- MYO N/A
- EPS Growth
- MHF N/A
- MYO N/A
- EPS
- MHF N/A
- MYO N/A
- Revenue
- MHF N/A
- MYO $40,760,091.00
- Revenue This Year
- MHF N/A
- MYO $52.68
- Revenue Next Year
- MHF N/A
- MYO $28.33
- P/E Ratio
- MHF N/A
- MYO N/A
- Revenue Growth
- MHF N/A
- MYO 93.08
- 52 Week Low
- MHF $5.92
- MYO $0.95
- 52 Week High
- MHF $6.79
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- MHF 51.29
- MYO 20.22
- Support Level
- MHF $6.82
- MYO $0.95
- Resistance Level
- MHF $6.95
- MYO $1.99
- Average True Range (ATR)
- MHF 0.10
- MYO 0.12
- MACD
- MHF 0.02
- MYO -0.06
- Stochastic Oscillator
- MHF 75.00
- MYO 15.60
About MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).